{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:20:56Z","timestamp":1791188456776,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T00:00:00Z","timestamp":1306195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Hidradenitis suppurativa (HS) is a severe chronic inflammatory follicular disease characterized by nodules and abscesses affecting apocrine gland\u2010bearing regions. HS is not well\u2010controlled with conventional medical therapies such as topical therapy, oral antibiotics and retinoids, however, abrogation of tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) function has proven effective in some patients.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To assess the safety and efficacy of the interleukin\u201012\/23 inhibitor, ustekinumab for treatment of HS in three patients with moderate\u2010severe disease.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> The subjects received 3\u201345\u2003mg subcutaneous injections of ustekinumab at 0, 1 and 4\u2003months. Improvement was assessed by the dermatology life quality index (DLQI), visual analogue scale of pain (VAS) and physician\u2019s global assessment (PGA) at each monthly visit.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Prior to treatment, subjects had moderate\u2010severe HS (Hurley stage II\u2010III) with a DLQI score between 8 and 12. At 6\u2003months, one patient showed complete disease remission, while a 25\u201349% improvement was seen in a second patient and no change in a third. A moderate but statistically significant relationship was observed between VAS and DLQI scores (<jats:italic>r<\/jats:italic>\u2003=\u20030.75; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Ustekinumab may provide a safe and effective new treatment strategy for HS in some patients. Interleukin 12\/23 inhibition is a potential therapeutic option for patients in which other therapies prove ineffective.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04123.x","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T09:18:18Z","timestamp":1306228698000},"page":"911-914","source":"Crossref","is-referenced-by-count":93,"title":["Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa"],"prefix":"10.1111","volume":"26","author":[{"given":"W.P.","family":"Gulliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2008.00712_1.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.911"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09198.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04137.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.061"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00087.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0747"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.050"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.72"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.027"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03293.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02272.x"},{"key":"e_1_2_5_14_2","first-page":"CS14","article-title":"Experiences with a long\u2010term treatment of a massive gluteal acne inversa with infliximab in Crohn\u2019s disease","volume":"15","author":"Goertz RS","year":"2009","journal-title":"Med Sci Monit"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2008.08034"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.49"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4917"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540300700109"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200111000-00008"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1540"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1185-9"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08332.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04123.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T08:32:33Z","timestamp":1697358753000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04123.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,24]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04123.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04123.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,24]]}}}